Andrew Bannister’s article ‘Don’t mention Ivermectin; it’ll upset the vaccine rollout’ was published on BizNews.com in May. The article gained an extensive amount of traction, which isn’t all that surprising considering mainstream media’s lack of coverage on alternative Covid-19 treatment.
TrialSite recently showcased what appears to be mounting safety issues with Sinopharm’s COVID-19 vaccine. Half-owned by the Chinese government, it’s one of a few controversial vaccines from China. Now doctors in the Southeastern Asian nation of Indonesia are dying after being vaccinated with CoronaVac, another COVID-19 vaccine developed by China’s Sinovac.
The recent upheaval in KwaZulu-Natal and Gauteng underscores an unmistakable truth: far from uplifting black South Africans and putting them on a par with their wealthier white compatriots who benefited from apartheid, over two decades of social engineering under the guise of Black Economic Empowerment (BEE) and related racial policies have produced dismal outcomes.
After the ruin, disgrace, and misery of the recent anarchy, South Africans are witnessing something inspiring as shopping malls are rebuilt, shelves restocked, security enhanced, and business struggles back to normal.
An Israeli biotech has developed an investigational, proprietary protein oral delivery (POD™) technology in the development of oral vaccines that are now only available via an imposing injection.
Recently, Laura Ingraham had Yale University epidemiologist Dr. Harvey Risch, a contributor to TrialSite News, as well as researcher and author Alex Berenson on her show to discuss taking an honest look at the trends behind breakthrough COVID-19 cases, or fully-vaccinated individuals who become infected with COVID-19, and also the growing call for more lockdowns and the use of masks.
The Biovac Institute reached a deal with Pfizer to prepare and deliver vaccine doses for the continent. It comes amid an increase of cases in Africa, where just 2% of the population have received a first dose.
In its latest weekly surveillance summary, the European Centre for Disease Prevention and Control (ECDC) documented that case rates in the European Union and the European Economic Area were at 89.6 per 100,000 people in the week ending July 11.
University of Iowa Carver College of Medicine led a multi-site study finding that the only formally approved drug by the U.S. Food and Drug Administration (FDA) actually led to lengthier hospitalization duration, or was associated with such an observation.
You now have the perfect opportunity to do the right thing. Everyone knows this was an attempted coup, and you’ve said as much, just in different words.